Keenan Robert J, Landreneau Rodney J, Maley Richard H, Singh Deepak, Macherey Robin, Bartley Susan, Santucci Tibetha
Division of Thoracic Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA.
Ann Thorac Surg. 2004 Jul;78(1):228-33; discussion 228-33. doi: 10.1016/j.athoracsur.2004.01.024.
Segmental resection for stage I non-small cell lung cancer remains controversial. Reports suggest that segmentectomy confers no advantage in preserving lung function and compromises survival. This study was undertaken to assess the validity of those assertions.
We retrospectively analyzed patients undergoing lobectomy (n = 147) or segmentectomy (n = 54) for stage I non-small cell lung cancer between March 1996 and June 2001. All patients were included in the survival analysis. Pulmonary function testing was obtained preoperatively and at 1 year and included forced vital capacity, forced expiratory volume in 1 second, maximum voluntary ventilation, diffusing capacity, and stair-stepper exercise. Patients with recurrent disease (lobectomy, n = 32; segmentectomy, n = 10) were excluded in the pulmonary function testing analysis to avoid the confounding variables of tumor or treatments.
Preoperative pulmonary function tests in segmentectomy patients were significantly reduced compared with lobectomy (forced expiratory volume in 1 second, 75.1% versus 55.3%; p < 0.001). At 1 year, lobectomy patients experienced significant declines in forced vital capacity (85.5% to 81.1%), forced expiratory volume in 1 second (75.1% to 66.7%), maximum voluntary ventilation (72.8% to 65.2%), and diffusing capacity (79.3% to 69.6%). In contrast, a decline in diffusing capacity was the only significant change seen after segmental resection. Oxygen saturations at rest and with exercise were maintained in both groups. Actuarial survival in both groups was similar (p = 0.406) with a 1-year survival of 95% for lobectomy and 92% for segmentectomy. Four-year survivals were 67% and 62%, respectively.
For patients with stage I non-small cell lung cancer, segmental resection offers preservation of pulmonary function compared with lobectomy and does not compromise survival. Segmentectomy should be considered whenever permitted by anatomic location.
I期非小细胞肺癌的肺段切除术仍存在争议。报告显示,肺段切除术在保留肺功能方面并无优势,且会影响生存率。本研究旨在评估这些观点的正确性。
我们回顾性分析了1996年3月至2001年6月期间因I期非小细胞肺癌接受肺叶切除术(n = 147)或肺段切除术(n = 54)的患者。所有患者均纳入生存分析。术前、术后1年进行肺功能测试,包括用力肺活量、第1秒用力呼气量、最大自主通气量、弥散功能和爬楼梯运动。在肺功能测试分析中排除复发疾病患者(肺叶切除术组n = 32;肺段切除术组n = 10),以避免肿瘤或治疗的混杂变量影响。
与肺叶切除术患者相比,肺段切除术患者术前肺功能测试结果显著降低(第1秒用力呼气量,分别为75.1%和55.3%;p < 0.001)。术后1年,肺叶切除术患者的用力肺活量(从85.5%降至81.1%)、第1秒用力呼气量(从75.1%降至66.7%)、最大自主通气量(从72.8%降至65.2%)和弥散功能(从79.3%降至69.6%)均显著下降。相比之下,肺段切除术后仅弥散功能下降有显著变化。两组患者静息和运动时的血氧饱和度均保持稳定。两组的精算生存率相似(p = 0.406),肺叶切除术组1年生存率为95%,肺段切除术组为92%。4年生存率分别为67%和62%。
对于I期非小细胞肺癌患者,与肺叶切除术相比,肺段切除术可保留肺功能,且不影响生存率。只要解剖位置允许,应考虑行肺段切除术。